speb/financial-data huggingface dataset:
IBIO cash_flow (annual, 2022-06-30) — Purchase Of Business: 0.00
IBIO cash_flow (annual, 2022-06-30) — Purchase Of Intangibles: -4300000.00
IBIO cash_flow (annual, 2022-06-30) — Purchase Of Investment: -7115000.00
IBIO cash_flow (annual, 2022-06-30) — Purchase Of PPE: -7330000.00
IBIO balance_sheet (annual, 2022-06-30) — Raw Materials: 3896000.00
IBIO balance_sheet (annual, 2022-06-30) — Receivables: 6100000.00
IBIO income_statement (annual, 2022-06-30) — Reconciled Cost Of Revenue: 216000.00
IBIO income_statement (annual, 2022-06-30) — Reconciled Depreciation: 3791000.00
IBIO cash_flow (annual, 2022-06-30) — Repayment Of Debt: -5830000.00
IBIO cash_flow (annual, 2022-06-30) — Repurchase Of Capital Stock: 0.00
IBIO income_statement (annual, 2022-06-30) — Research And Development: 9827000.00
IBIO balance_sheet (annual, 2022-06-30) — Restricted Cash: 0.00
IBIO balance_sheet (annual, 2022-06-30) — Retained Earnings: -223930000.00
IBIO cash_flow (annual, 2022-06-30) — Sale Of Investment: 13618000.00
IBIO cash_flow (annual, 2022-06-30) — Sale Of PPE: 0.00
IBIO income_statement (annual, 2022-06-30) — Selling General And Administration: 21754000.00
IBIO balance_sheet (annual, 2022-06-30) — Share Issued: 436357.00
IBIO cash_flow (annual, 2022-06-30) — Short Term Debt Payments: 0.00
IBIO income_statement (annual, 2022-06-30) — Special Income Charges: 607000.00
IBIO cash_flow (annual, 2022-06-30) — Stock Based Compensation: 4377000.00
IBIO balance_sheet (annual, 2022-06-30) — Stockholders Equity: 63485000.00
IBIO balance_sheet (annual, 2022-06-30) — Tangible Book Value: 58634000.00
IBIO income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
IBIO income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.00
IBIO balance_sheet (annual, 2022-06-30) — Total Assets: 99406000.00
IBIO balance_sheet (annual, 2022-06-30) — Total Capitalization: 63485000.00
IBIO balance_sheet (annual, 2022-06-30) — Total Debt: 25766000.00
IBIO balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 63485000.00
IBIO income_statement (annual, 2022-06-30) — Total Expenses: 31581000.00
IBIO balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 35921000.00
IBIO balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 54336000.00
IBIO balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 5485000.00
IBIO income_statement (annual, 2022-06-30) — Total Operating Income As Reported: -29697000.00
IBIO balance_sheet (annual, 2022-06-30) — Total Tax Payable: 284000.00
IBIO income_statement (annual, 2022-06-30) — Total Unusual Items: 607000.00
IBIO income_statement (annual, 2022-06-30) — Total Unusual Items Excluding Goodwill: 607000.00
IBIO balance_sheet (annual, 2022-06-30) — Tradeand Other Payables Non Current: 0.00
IBIO balance_sheet (annual, 2022-06-30) — Work In Process: 4000.00
IBIO balance_sheet (annual, 2022-06-30) — Working Capital: 14634000.00
IBIO income_statement (annual, 2023-06-30) — +Operating Expense: 29343000.00
IBIO income_statement (annual, 2023-06-30) — +Total Revenue: 0.00
IBIO balance_sheet (annual, 2023-06-30) — Accounts Payable: 1849000.00
IBIO balance_sheet (annual, 2023-06-30) — Accounts Receivable: 0.00
IBIO balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -604000.00
IBIO balance_sheet (annual, 2023-06-30) — Additional Paid In Capital: 304320000.00
IBIO cash_flow (annual, 2023-06-30) — Amortization Cash Flow: 126000.00
IBIO cash_flow (annual, 2023-06-30) — Amortization Of Intangibles: 126000.00
IBIO cash_flow (annual, 2023-06-30) — Amortization Of Securities: 67000.00
IBIO cash_flow (annual, 2023-06-30) — Asset Impairment Charge: 18465000.00
IBIO balance_sheet (annual, 2023-06-30) — Assets Held For Sale Current: 18065000.00
IBIO income_statement (annual, 2023-06-30) — Basic Average Shares: 612000.00
IBIO income_statement (annual, 2023-06-30) — Basic EPS: -106.19
IBIO cash_flow (annual, 2023-06-30) — Beginning Cash Position: 28672000.00
IBIO balance_sheet (annual, 2023-06-30) — Buildings And Improvements: 695000.00
IBIO cash_flow (annual, 2023-06-30) — Capital Expenditure: -5738000.00
IBIO balance_sheet (annual, 2023-06-30) — Capital Lease Obligations: 4137000.00
IBIO balance_sheet (annual, 2023-06-30) — Capital Stock: 1000.00
IBIO balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 4301000.00
IBIO balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 4301000.00
IBIO cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 2301000.00
IBIO cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: 7009000.00
IBIO cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Operating Activities: -30436000.00
IBIO cash_flow (annual, 2023-06-30) — Change In Account Payable: -625000.00
IBIO cash_flow (annual, 2023-06-30) — Change In Accrued Expense: 672000.00
IBIO cash_flow (annual, 2023-06-30) — Change In Inventory: -1015000.00
IBIO cash_flow (annual, 2023-06-30) — Change In Other Current Liabilities: -101000.00
IBIO cash_flow (annual, 2023-06-30) — Change In Other Working Capital: -100000.00
IBIO cash_flow (annual, 2023-06-30) — Change In Payable: -625000.00
IBIO cash_flow (annual, 2023-06-30) — Change In Payables And Accrued Expense: 47000.00
IBIO cash_flow (annual, 2023-06-30) — Change In Prepaid Assets: 938000.00
IBIO cash_flow (annual, 2023-06-30) — Change In Receivables: 6100000.00
IBIO cash_flow (annual, 2023-06-30) — Change In Working Capital: 5869000.00
IBIO cash_flow (annual, 2023-06-30) — Changes In Account Receivables: 1000000.00
IBIO cash_flow (annual, 2023-06-30) — Changes In Cash: -21126000.00
IBIO balance_sheet (annual, 2023-06-30) — Common Stock: 1000.00
IBIO balance_sheet (annual, 2023-06-30) — Common Stock Equity: 15381000.00
IBIO cash_flow (annual, 2023-06-30) — Common Stock Issuance: 11487000.00
IBIO cash_flow (annual, 2023-06-30) — Common Stock Payments: -39000.00
IBIO balance_sheet (annual, 2023-06-30) — Construction In Progress: 0.00
IBIO balance_sheet (annual, 2023-06-30) — Current Accrued Expenses: 414000.00
IBIO balance_sheet (annual, 2023-06-30) — Current Assets: 26259000.00
IBIO balance_sheet (annual, 2023-06-30) — Current Capital Lease Obligation: 661000.00
IBIO balance_sheet (annual, 2023-06-30) — Current Debt: 12937000.00
IBIO balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 13598000.00
IBIO balance_sheet (annual, 2023-06-30) — Current Deferred Liabilities: 0.00
IBIO balance_sheet (annual, 2023-06-30) — Current Deferred Revenue: 0.00
IBIO balance_sheet (annual, 2023-06-30) — Current Liabilities: 22109000.00
IBIO balance_sheet (annual, 2023-06-30) — Current Notes Payable: 12937000.00
IBIO cash_flow (annual, 2023-06-30) — Depreciation: 1254000.00
IBIO cash_flow (annual, 2023-06-30) — Depreciation Amortization Depletion: 1380000.00
IBIO cash_flow (annual, 2023-06-30) — Depreciation And Amortization: 1380000.00
IBIO income_statement (annual, 2023-06-30) — Diluted Average Shares: 612000.00
IBIO income_statement (annual, 2023-06-30) — Diluted EPS: -106.19
IBIO income_statement (annual, 2023-06-30) — Diluted NI Availto Com Stockholders: -65010000.00
IBIO income_statement (annual, 2023-06-30) — EBIT: -29228000.00
IBIO income_statement (annual, 2023-06-30) — EBITDA: -27848000.00
IBIO cash_flow (annual, 2023-06-30) — Effect Of Exchange Rate Changes: 33000.00
IBIO cash_flow (annual, 2023-06-30) — End Cash Position: 7579000.00
IBIO cash_flow (annual, 2023-06-30) — Financing Cash Flow: 2301000.00
IBIO cash_flow (annual, 2023-06-30) — Free Cash Flow: -36174000.00
IBIO cash_flow (annual, 2023-06-30) — Gain Loss On Investment Securities: 98000.00
IBIO cash_flow (annual, 2023-06-30) — Gain Loss On Sale Of PPE: -773000.00
IBIO income_statement (annual, 2023-06-30) — Gain On Sale Of Ppe: 0.00
IBIO income_statement (annual, 2023-06-30) — Gain On Sale Of Security: -98000.00
IBIO balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 0.00
IBIO income_statement (annual, 2023-06-30) — General And Administrative Expense: 19016000.00
IBIO balance_sheet (annual, 2023-06-30) — Goodwill And Other Intangible Assets: 5388000.00
IBIO balance_sheet (annual, 2023-06-30) — Gross PPE: 8155000.00
IBIO income_statement (annual, 2023-06-30) — Interest Expense: 83000.00
IBIO income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 83000.00
IBIO income_statement (annual, 2023-06-30) — Interest Income: 213000.00
IBIO income_statement (annual, 2023-06-30) — Interest Income Non Operating: 213000.00
IBIO cash_flow (annual, 2023-06-30) — Interest Paid Supplemental Data: 687000.00
IBIO balance_sheet (annual, 2023-06-30) — Interest Payable: 183000.00
IBIO balance_sheet (annual, 2023-06-30) — Invested Capital: 28318000.00
IBIO cash_flow (annual, 2023-06-30) — Investing Cash Flow: 7009000.00
IBIO cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 11487000.00
IBIO cash_flow (annual, 2023-06-30) — Issuance Of Debt: 500000.00
IBIO balance_sheet (annual, 2023-06-30) — Liabilities Heldfor Sale Non Current: 0.00
IBIO balance_sheet (annual, 2023-06-30) — Long Term Capital Lease Obligation: 3476000.00
IBIO balance_sheet (annual, 2023-06-30) — Long Term Debt And Capital Lease Obligation: 3476000.00
IBIO cash_flow (annual, 2023-06-30) — Long Term Debt Issuance: 500000.00
IBIO cash_flow (annual, 2023-06-30) — Long Term Debt Payments: -307000.00
IBIO balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 3924000.00
IBIO income_statement (annual, 2023-06-30) — Minority Interests: 0.00
IBIO cash_flow (annual, 2023-06-30) — Net Business Purchase And Sale: -692000.00
IBIO cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 11448000.00
IBIO balance_sheet (annual, 2023-06-30) — Net Debt: 8636000.00
IBIO income_statement (annual, 2023-06-30) — Net Income: -65010000.00
IBIO income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -65010000.00
IBIO income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -29311000.00
IBIO income_statement (annual, 2023-06-30) — Net Income Discontinuous Operations: -35699000.00
IBIO income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -65010000.00
IBIO income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -29311000.00
IBIO cash_flow (annual, 2023-06-30) — Net Income From Continuing Operations: -65010000.00
IBIO income_statement (annual, 2023-06-30) — Net Income From Tax Loss Carryforward: 0.00
IBIO income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -65010000.00
IBIO cash_flow (annual, 2023-06-30) — Net Intangibles Purchase And Sale: 0.00
IBIO income_statement (annual, 2023-06-30) — Net Interest Income: 130000.00
IBIO cash_flow (annual, 2023-06-30) — Net Investment Purchase And Sale: 10839000.00
IBIO cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: -9125000.00
IBIO cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: 193000.00
IBIO income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: 130000.00
IBIO cash_flow (annual, 2023-06-30) — Net Other Financing Charges: -22000.00
IBIO balance_sheet (annual, 2023-06-30) — Net PPE: 7551000.00
IBIO cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -3138000.00
IBIO cash_flow (annual, 2023-06-30) — Net Short Term Debt Issuance: -9318000.00
IBIO balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 9993000.00
IBIO balance_sheet (annual, 2023-06-30) — Non Current Accrued Expenses: 527000.00
IBIO balance_sheet (annual, 2023-06-30) — Non Current Note Receivables: 1706000.00
IBIO balance_sheet (annual, 2023-06-30) — Non Current Prepaid Assets: 50000.00
IBIO income_statement (annual, 2023-06-30) — Normalized EBITDA: -27750000.00
IBIO income_statement (annual, 2023-06-30) — Normalized Income: -29213000.00
IBIO balance_sheet (annual, 2023-06-30) — Notes Receivable: 0.00
IBIO cash_flow (annual, 2023-06-30) — Operating Cash Flow: -30436000.00
IBIO cash_flow (annual, 2023-06-30) — Operating Gains Losses: -680000.00
IBIO income_statement (annual, 2023-06-30) — Operating Income: -29343000.00
IBIO income_statement (annual, 2023-06-30) — Operating Revenue: 0.00
IBIO balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 1015503.00
IBIO balance_sheet (annual, 2023-06-30) — Other Current Assets: 664000.00
IBIO balance_sheet (annual, 2023-06-30) — Other Current Liabilities: 1941000.00
IBIO income_statement (annual, 2023-06-30) — Other Gand A: 19016000.00
IBIO income_statement (annual, 2023-06-30) — Other Income Expense: -98000.00
IBIO balance_sheet (annual, 2023-06-30) — Other Intangible Assets: 5388000.00
IBIO cash_flow (annual, 2023-06-30) — Other Non Cash Items: 167000.00
IBIO balance_sheet (annual, 2023-06-30) — Other Non Current Assets: 253000.00
IBIO balance_sheet (annual, 2023-06-30) — Other Payable: 160000.00
IBIO balance_sheet (annual, 2023-06-30) — Other Properties: 3536000.00
IBIO balance_sheet (annual, 2023-06-30) — Other Receivables: 204000.00
IBIO balance_sheet (annual, 2023-06-30) — Other Short Term Investments: 0.00
IBIO balance_sheet (annual, 2023-06-30) — Payables: 2277000.00
IBIO balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 2691000.00
IBIO balance_sheet (annual, 2023-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 3879000.00
IBIO balance_sheet (annual, 2023-06-30) — Preferred Stock: 0.00
IBIO income_statement (annual, 2023-06-30) — Pretax Income: -29311000.00
IBIO cash_flow (annual, 2023-06-30) — Proceeds From Stock Option Exercised: 0.00
IBIO balance_sheet (annual, 2023-06-30) — Properties: 0.00
IBIO cash_flow (annual, 2023-06-30) — Provisionand Write Offof Assets: 4915000.00
IBIO cash_flow (annual, 2023-06-30) — Purchase Of Business: -692000.00
IBIO cash_flow (annual, 2023-06-30) — Purchase Of Intangibles: 0.00
IBIO cash_flow (annual, 2023-06-30) — Purchase Of Investment: 0.00
IBIO cash_flow (annual, 2023-06-30) — Purchase Of PPE: -5738000.00
IBIO balance_sheet (annual, 2023-06-30) — Receivables: 204000.00
IBIO income_statement (annual, 2023-06-30) — Reconciled Depreciation: 1380000.00
IBIO cash_flow (annual, 2023-06-30) — Repayment Of Debt: -9625000.00
IBIO cash_flow (annual, 2023-06-30) — Repurchase Of Capital Stock: -39000.00
IBIO income_statement (annual, 2023-06-30) — Research And Development: 10327000.00
IBIO balance_sheet (annual, 2023-06-30) — Restricted Cash: 3025000.00
IBIO balance_sheet (annual, 2023-06-30) — Retained Earnings: -288940000.00
IBIO cash_flow (annual, 2023-06-30) — Sale Of Intangibles: 0.00
IBIO cash_flow (annual, 2023-06-30) — Sale Of Investment: 10839000.00
IBIO cash_flow (annual, 2023-06-30) — Sale Of PPE: 2600000.00
IBIO income_statement (annual, 2023-06-30) — Selling General And Administration: 19016000.00
IBIO balance_sheet (annual, 2023-06-30) — Share Issued: 1015503.00
IBIO cash_flow (annual, 2023-06-30) — Short Term Debt Payments: -9318000.00
IBIO income_statement (annual, 2023-06-30) — Special Income Charges: 0.00
IBIO cash_flow (annual, 2023-06-30) — Stock Based Compensation: 4391000.00
IBIO balance_sheet (annual, 2023-06-30) — Stockholders Equity: 15381000.00
IBIO balance_sheet (annual, 2023-06-30) — Tangible Book Value: 9993000.00
IBIO income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
IBIO income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
IBIO balance_sheet (annual, 2023-06-30) — Total Assets: 41207000.00
IBIO balance_sheet (annual, 2023-06-30) — Total Capitalization: 15381000.00
IBIO balance_sheet (annual, 2023-06-30) — Total Debt: 17074000.00
IBIO balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 15381000.00
IBIO income_statement (annual, 2023-06-30) — Total Expenses: 29343000.00
IBIO balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 25826000.00
IBIO balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 14948000.00
IBIO balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 3717000.00
IBIO income_statement (annual, 2023-06-30) — Total Operating Income As Reported: -29343000.00
IBIO balance_sheet (annual, 2023-06-30) — Total Tax Payable: 268000.00
IBIO income_statement (annual, 2023-06-30) — Total Unusual Items: -98000.00
IBIO income_statement (annual, 2023-06-30) — Total Unusual Items Excluding Goodwill: -98000.00
IBIO balance_sheet (annual, 2023-06-30) — Tradeand Other Payables Non Current: 241000.00
IBIO balance_sheet (annual, 2023-06-30) — Working Capital: 4150000.00
IBIO income_statement (annual, 2024-06-30) — +Operating Expense: 16859000.00
IBIO income_statement (annual, 2024-06-30) — +Total Revenue: 225000.00
IBIO balance_sheet (annual, 2024-06-30) — Accounts Payable: 358000.00
IBIO balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -1486000.00
IBIO balance_sheet (annual, 2024-06-30) — Additional Paid In Capital: 335162000.00
IBIO cash_flow (annual, 2024-06-30) — Amortization Cash Flow: 20000.00
IBIO cash_flow (annual, 2024-06-30) — Amortization Of Intangibles: 20000.00
IBIO cash_flow (annual, 2024-06-30) — Amortization Of Securities: 0.00
IBIO cash_flow (annual, 2024-06-30) — Asset Impairment Charge: 3100000.00
IBIO balance_sheet (annual, 2024-06-30) — Assets Held For Sale Current: 0.00
IBIO income_statement (annual, 2024-06-30) — Basic Average Shares: 3831000.00
IBIO income_statement (annual, 2024-06-30) — Basic EPS: -6.50
IBIO cash_flow (annual, 2024-06-30) — Beginning Cash Position: 7579000.00
IBIO balance_sheet (annual, 2024-06-30) — Buildings And Improvements: 695000.00
IBIO cash_flow (annual, 2024-06-30) — Capital Expenditure: -210000.00
IBIO balance_sheet (annual, 2024-06-30) — Capital Lease Obligations: 3476000.00
IBIO balance_sheet (annual, 2024-06-30) — Capital Stock: 9000.00
IBIO balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 14210000.00
IBIO balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 14210000.00
IBIO cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 24494000.00
IBIO cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: 906000.00
IBIO cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Operating Activities: -18554000.00
IBIO cash_flow (annual, 2024-06-30) — Change In Account Payable: -1491000.00
IBIO cash_flow (annual, 2024-06-30) — Change In Accrued Expense: -1726000.00
IBIO cash_flow (annual, 2024-06-30) — Change In Inventory: 0.00
IBIO cash_flow (annual, 2024-06-30) — Change In Other Current Liabilities: -389000.00
IBIO cash_flow (annual, 2024-06-30) — Change In Other Working Capital: 200000.00
IBIO cash_flow (annual, 2024-06-30) — Change In Payable: -1491000.00
IBIO cash_flow (annual, 2024-06-30) — Change In Payables And Accrued Expense: -3217000.00
IBIO cash_flow (annual, 2024-06-30) — Change In Prepaid Assets: 238000.00
IBIO cash_flow (annual, 2024-06-30) — Change In Receivables: 0.00
IBIO cash_flow (annual, 2024-06-30) — Change In Working Capital: -3168000.00
IBIO cash_flow (annual, 2024-06-30) — Changes In Account Receivables: 0.00
IBIO cash_flow (annual, 2024-06-30) — Changes In Cash: 6846000.00
IBIO balance_sheet (annual, 2024-06-30) — Common Stock: 9000.00
IBIO balance_sheet (annual, 2024-06-30) — Common Stock Equity: 21324000.00
IBIO cash_flow (annual, 2024-06-30) — Common Stock Issuance: 25523000.00
IBIO cash_flow (annual, 2024-06-30) — Common Stock Payments: -7000.00
IBIO balance_sheet (annual, 2024-06-30) — Current Accrued Expenses: 460000.00
IBIO balance_sheet (annual, 2024-06-30) — Current Assets: 15672000.00
IBIO balance_sheet (annual, 2024-06-30) — Current Capital Lease Obligation: 735000.00
IBIO balance_sheet (annual, 2024-06-30) — Current Debt: 218000.00
IBIO balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 953000.00
IBIO balance_sheet (annual, 2024-06-30) — Current Deferred Liabilities: 200000.00
IBIO balance_sheet (annual, 2024-06-30) — Current Deferred Revenue: 200000.00
IBIO balance_sheet (annual, 2024-06-30) — Current Liabilities: 3840000.00
IBIO balance_sheet (annual, 2024-06-30) — Current Notes Payable: 0.00
IBIO cash_flow (annual, 2024-06-30) — Depreciation: 1230000.00
IBIO cash_flow (annual, 2024-06-30) — Depreciation Amortization Depletion: 1250000.00
IBIO cash_flow (annual, 2024-06-30) — Depreciation And Amortization: 1250000.00
IBIO income_statement (annual, 2024-06-30) — Diluted Average Shares: 3831000.00
IBIO income_statement (annual, 2024-06-30) — Diluted EPS: -6.50
IBIO income_statement (annual, 2024-06-30) — Diluted NI Availto Com Stockholders: -24907000.00
IBIO income_statement (annual, 2024-06-30) — EBIT: -15271000.00
IBIO income_statement (annual, 2024-06-30) — EBITDA: -14021000.00
IBIO cash_flow (annual, 2024-06-30) — Effect Of Exchange Rate Changes: 0.00
IBIO cash_flow (annual, 2024-06-30) — End Cash Position: 14425000.00
IBIO cash_flow (annual, 2024-06-30) — Financing Cash Flow: 24494000.00
IBIO cash_flow (annual, 2024-06-30) — Free Cash Flow: -18764000.00
IBIO cash_flow (annual, 2024-06-30) — Gain Loss On Sale Of PPE: 3909000.00
IBIO income_statement (annual, 2024-06-30) — Gain On Sale Of Ppe: 1000000.00
IBIO income_statement (annual, 2024-06-30) — General And Administrative Expense: 11674000.00
IBIO balance_sheet (annual, 2024-06-30) — Goodwill And Other Intangible Assets: 5368000.00
IBIO balance_sheet (annual, 2024-06-30) — Gross PPE: 7858000.00
IBIO income_statement (annual, 2024-06-30) — Interest Expense: 172000.00
IBIO income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 172000.00
IBIO income_statement (annual, 2024-06-30) — Interest Income: 363000.00
IBIO income_statement (annual, 2024-06-30) — Interest Income Non Operating: 363000.00
IBIO cash_flow (annual, 2024-06-30) — Interest Paid Supplemental Data: 749000.00
IBIO balance_sheet (annual, 2024-06-30) — Interest Payable: 0.00
IBIO cash_flow (annual, 2024-06-30) — Interest Received Cfi: 0.00
IBIO balance_sheet (annual, 2024-06-30) — Invested Capital: 22308000.00
IBIO cash_flow (annual, 2024-06-30) — Investing Cash Flow: 906000.00
IBIO cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 25523000.00
IBIO cash_flow (annual, 2024-06-30) — Issuance Of Debt: 895000.00
IBIO balance_sheet (annual, 2024-06-30) — Long Term Capital Lease Obligation: 2741000.00
IBIO balance_sheet (annual, 2024-06-30) — Long Term Debt: 766000.00
IBIO balance_sheet (annual, 2024-06-30) — Long Term Debt And Capital Lease Obligation: 3507000.00
IBIO cash_flow (annual, 2024-06-30) — Long Term Debt Issuance: 895000.00
IBIO cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -520000.00
IBIO balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 3948000.00
IBIO cash_flow (annual, 2024-06-30) — Net Business Purchase And Sale: 0.00
IBIO cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 25516000.00
IBIO income_statement (annual, 2024-06-30) — Net Income: -24907000.00
IBIO income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -24907000.00
IBIO income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -15443000.00
IBIO income_statement (annual, 2024-06-30) — Net Income Discontinuous Operations: -9464000.00
IBIO income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -24907000.00
IBIO income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -15443000.00
IBIO cash_flow (annual, 2024-06-30) — Net Income From Continuing Operations: -24907000.00
IBIO income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -24907000.00
IBIO cash_flow (annual, 2024-06-30) — Net Intangibles Purchase And Sale: 1000000.00
IBIO income_statement (annual, 2024-06-30) — Net Interest Income: 191000.00
IBIO cash_flow (annual, 2024-06-30) — Net Investment Purchase And Sale: 0.00
IBIO cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: -1138000.00
IBIO cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: 375000.00
IBIO income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: 191000.00
IBIO cash_flow (annual, 2024-06-30) — Net Other Financing Charges: 116000.00
IBIO balance_sheet (annual, 2024-06-30) — Net PPE: 6372000.00
IBIO cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -94000.00
IBIO cash_flow (annual, 2024-06-30) — Net Short Term Debt Issuance: -1513000.00
IBIO balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 15956000.00
IBIO balance_sheet (annual, 2024-06-30) — Non Current Note Receivables: 1081000.00
IBIO balance_sheet (annual, 2024-06-30) — Non Current Prepaid Assets: 26000.00
IBIO income_statement (annual, 2024-06-30) — Normalized EBITDA: -15021000.00
IBIO income_statement (annual, 2024-06-30) — Normalized Income: -16443000.00
IBIO balance_sheet (annual, 2024-06-30) — Notes Receivable: 713000.00
IBIO cash_flow (annual, 2024-06-30) — Operating Cash Flow: -18554000.00
IBIO cash_flow (annual, 2024-06-30) — Operating Gains Losses: 3101000.00
IBIO income_statement (annual, 2024-06-30) — Operating Income: -16634000.00
IBIO income_statement (annual, 2024-06-30) — Operating Revenue: 225000.00
IBIO balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 8623676.00
IBIO balance_sheet (annual, 2024-06-30) — Other Current Assets: 749000.00
IBIO balance_sheet (annual, 2024-06-30) — Other Current Borrowings: 218000.00
IBIO income_statement (annual, 2024-06-30) — Other Gand A: 11674000.00
IBIO income_statement (annual, 2024-06-30) — Other Income Expense: 1000000.00
IBIO balance_sheet (annual, 2024-06-30) — Other Intangible Assets: 5368000.00
IBIO cash_flow (annual, 2024-06-30) — Other Non Cash Items: 32000.00
IBIO balance_sheet (annual, 2024-06-30) — Other Non Current Assets: 215000.00
IBIO balance_sheet (annual, 2024-06-30) — Other Payable: 301000.00
IBIO balance_sheet (annual, 2024-06-30) — Other Properties: 3215000.00
IBIO balance_sheet (annual, 2024-06-30) — Payables: 659000.00
IBIO balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 1119000.00
IBIO balance_sheet (annual, 2024-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 1568000.00
IBIO balance_sheet (annual, 2024-06-30) — Preferred Stock: 0.00
IBIO income_statement (annual, 2024-06-30) — Pretax Income: -15443000.00
IBIO cash_flow (annual, 2024-06-30) — Proceeds From Stock Option Exercised: 0.00
IBIO balance_sheet (annual, 2024-06-30) — Properties: 0.00
IBIO cash_flow (annual, 2024-06-30) — Provisionand Write Offof Assets: 0.00
IBIO cash_flow (annual, 2024-06-30) — Purchase Of Business: 0.00
IBIO cash_flow (annual, 2024-06-30) — Purchase Of PPE: -210000.00
IBIO balance_sheet (annual, 2024-06-30) — Receivables: 713000.00
IBIO income_statement (annual, 2024-06-30) — Reconciled Depreciation: 1250000.00
IBIO cash_flow (annual, 2024-06-30) — Repayment Of Debt: -2033000.00
IBIO cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -7000.00
IBIO income_statement (annual, 2024-06-30) — Research And Development: 5185000.00
IBIO balance_sheet (annual, 2024-06-30) — Restricted Cash: 0.00
IBIO balance_sheet (annual, 2024-06-30) — Retained Earnings: -313847000.00
IBIO cash_flow (annual, 2024-06-30) — Sale Of Intangibles: 1000000.00
IBIO cash_flow (annual, 2024-06-30) — Sale Of Investment: 0.00
IBIO cash_flow (annual, 2024-06-30) — Sale Of PPE: 116000.00
IBIO income_statement (annual, 2024-06-30) — Selling General And Administration: 11674000.00
IBIO balance_sheet (annual, 2024-06-30) — Share Issued: 8623676.00
IBIO cash_flow (annual, 2024-06-30) — Short Term Debt Payments: -1513000.00
IBIO income_statement (annual, 2024-06-30) — Special Income Charges: 1000000.00
IBIO cash_flow (annual, 2024-06-30) — Stock Based Compensation: 2038000.00
IBIO balance_sheet (annual, 2024-06-30) — Stockholders Equity: 21324000.00
IBIO balance_sheet (annual, 2024-06-30) — Tangible Book Value: 15956000.00
IBIO income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
IBIO income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.00
IBIO balance_sheet (annual, 2024-06-30) — Total Assets: 28734000.00
IBIO balance_sheet (annual, 2024-06-30) — Total Capitalization: 22090000.00
IBIO balance_sheet (annual, 2024-06-30) — Total Debt: 4460000.00
IBIO balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 21324000.00
IBIO income_statement (annual, 2024-06-30) — Total Expenses: 16859000.00
IBIO balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 7410000.00
IBIO balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 13062000.00
IBIO balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 3570000.00
IBIO income_statement (annual, 2024-06-30) — Total Operating Income As Reported: -16634000.00
IBIO balance_sheet (annual, 2024-06-30) — Total Tax Payable: 0.00
IBIO income_statement (annual, 2024-06-30) — Total Unusual Items: 1000000.00
IBIO income_statement (annual, 2024-06-30) — Total Unusual Items Excluding Goodwill: 1000000.00
IBIO balance_sheet (annual, 2024-06-30) — Tradeand Other Payables Non Current: 63000.00
IBIO balance_sheet (annual, 2024-06-30) — Treasury Shares Number: 0.00
IBIO balance_sheet (annual, 2024-06-30) — Working Capital: 11832000.00
IBIO balance_sheet (quarterly, 2024-09-30) — Current Debt: 227000.00
IBIO cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: 0.00
IBIO balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 706000.00
IBIO income_statement (quarterly, 2024-09-30) — Net Income Discontinuous Operations: 0.00
IBIO balance_sheet (quarterly, 2024-09-30) — Notes Receivable: 0.00
IBIO balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 227000.00
IBIO balance_sheet (quarterly, 2024-09-30) — Other Payable: 182000.00
IBIO cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 0.00
IBIO balance_sheet (quarterly, 2024-09-30) — Tradeand Other Payables Non Current: 16000.00
IBIO cash_flow (quarterly, 2024-12-31) — Amortization Of Securities: 0.00
IBIO income_statement (quarterly, 2024-12-31) — Basic Average Shares: 9132000.00
IBIO income_statement (quarterly, 2024-12-31) — Basic EPS: -0.48
IBIO cash_flow (quarterly, 2024-12-31) — Change In Receivables: 0.00
IBIO cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: 0.00
IBIO balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 1000.00
IBIO balance_sheet (quarterly, 2024-12-31) — Current Debt: 237000.00
IBIO income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 9132000.00
IBIO income_statement (quarterly, 2024-12-31) — Diluted EPS: -0.48
IBIO cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
IBIO balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 643000.00
IBIO income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: 0.00
IBIO cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
IBIO balance_sheet (quarterly, 2024-12-31) — Notes Receivable: 0.00
IBIO balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 237000.00
IBIO balance_sheet (quarterly, 2024-12-31) — Other Payable: 756000.00
IBIO balance_sheet (quarterly, 2024-12-31) — Other Receivables: 13000.00
IBIO cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 0.00
IBIO cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
IBIO balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 0.00
IBIO income_statement (quarterly, 2025-03-31) — +Operating Expense: 4879000.00
IBIO income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
IBIO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1477000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2052000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 338432000.00
IBIO cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 5000.00
IBIO cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 5000.00
IBIO cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: 0.00
IBIO cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
IBIO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 9862000.00
IBIO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.49
IBIO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 7238000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 695000.00
IBIO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -14000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2931000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 10000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 4959000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 4959000.00
IBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 1063000.00
IBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -14000.00
IBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -3105000.00
IBIO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 863000.00
IBIO cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 240000.00
IBIO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -110000.00
IBIO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 0.00
IBIO cash_flow (quarterly, 2025-03-31) — Change In Payable: 863000.00
IBIO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 1103000.00
IBIO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 125000.00
IBIO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 0.00
IBIO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 1118000.00
IBIO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 0.00
IBIO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -2056000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Common Stock: 10000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 11381000.00
IBIO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 1127000.00
IBIO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
IBIO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 1325000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Current Assets: 6060000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 606000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Current Debt: 824000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1430000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 600000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 600000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 5397000.00
IBIO cash_flow (quarterly, 2025-03-31) — Depreciation: 277000.00
IBIO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 282000.00
IBIO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 282000.00
IBIO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 9862000.00
IBIO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.49
IBIO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -4861000.00
IBIO income_statement (quarterly, 2025-03-31) — EBIT: -4807000.00
IBIO income_statement (quarterly, 2025-03-31) — EBITDA: -4525000.00
IBIO cash_flow (quarterly, 2025-03-31) — End Cash Position: 5182000.00
IBIO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 1063000.00
IBIO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -3119000.00
IBIO cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
IBIO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 0.00
IBIO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2973000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 6103000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 7614000.00
IBIO income_statement (quarterly, 2025-03-31) — Interest Expense: 54000.00
IBIO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 54000.00
IBIO income_statement (quarterly, 2025-03-31) — Interest Income: 72000.00
IBIO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 72000.00
IBIO cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 54000.00
IBIO cash_flow (quarterly, 2025-03-31) — Interest Received Cfi: 0.00
IBIO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 12205000.00
IBIO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -14000.00
IBIO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 1127000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2325000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2325000.00
IBIO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -176000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 3963000.00
IBIO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 1127000.00
IBIO income_statement (quarterly, 2025-03-31) — Net Income: -4861000.00
IBIO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -4861000.00
IBIO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -4861000.00
IBIO income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 0.00
IBIO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -4861000.00
IBIO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -4861000.00
IBIO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -4861000.00
IBIO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -4861000.00
IBIO income_statement (quarterly, 2025-03-31) — Net Interest Income: 18000.00
IBIO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
IBIO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -176000.00
IBIO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -176000.00
IBIO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 18000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Net PPE: 5562000.00
IBIO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -14000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 5278000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Non Current Note Receivables: 1129000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 26000.00
IBIO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -4525000.00
IBIO income_statement (quarterly, 2025-03-31) — Normalized Income: -4861000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Notes Receivable: 0.00
IBIO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -3105000.00
IBIO income_statement (quarterly, 2025-03-31) — Operating Income: -4879000.00
IBIO income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
IBIO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 10066276.00
IBIO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1101000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 824000.00
IBIO income_statement (quarterly, 2025-03-31) — Other Gand A: 2973000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 6103000.00
IBIO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -14000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 223000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Other Payable: 565000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Other Properties: 2956000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Payables: 2042000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 3367000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
IBIO income_statement (quarterly, 2025-03-31) — Pretax Income: -4861000.00
IBIO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 112000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
IBIO cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 0.00
IBIO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
IBIO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -14000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Receivables: 0.00
IBIO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 282000.00
IBIO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -176000.00
IBIO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
IBIO income_statement (quarterly, 2025-03-31) — Research And Development: 1906000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -327061000.00
IBIO cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
IBIO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2973000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Share Issued: 10066276.00
IBIO income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
IBIO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 370000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 11381000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 5278000.00
IBIO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IBIO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
IBIO balance_sheet (quarterly, 2025-03-31) — Total Assets: 19103000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 11381000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Total Debt: 3755000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 11381000.00
IBIO income_statement (quarterly, 2025-03-31) — Total Expenses: 4879000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 7722000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 13043000.00
IBIO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2325000.00
IBIO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -4879000.00
IBIO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
IBIO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
IBIO balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 0.00
IBIO balance_sheet (quarterly, 2025-03-31) — Working Capital: 663000.00
IBIO income_statement (annual, 2025-06-30) — +Operating Expense: 19002000.00
IBIO income_statement (quarterly, 2025-06-30) — +Operating Expense: 5398000.00
IBIO income_statement (annual, 2025-06-30) — +Total Revenue: 400000.00
IBIO income_statement (quarterly, 2025-06-30) — +Total Revenue: 200000.00
IBIO balance_sheet (annual, 2025-06-30) — Accounts Payable: 2188000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 2188000.00
IBIO balance_sheet (annual, 2025-06-30) — Accumulated Depreciation: -2241000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -2241000.00
IBIO balance_sheet (annual, 2025-06-30) — Additional Paid In Capital: 347085000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 347085000.00
IBIO cash_flow (annual, 2025-06-30) — Amortization Cash Flow: 20000.00
IBIO cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 5000.00
IBIO cash_flow (annual, 2025-06-30) — Amortization Of Intangibles: 20000.00
IBIO cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 5000.00
IBIO cash_flow (annual, 2025-06-30) — Asset Impairment Charge: 0.00
IBIO cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
IBIO income_statement (annual, 2025-06-30) — Basic Average Shares: 10499000.00
IBIO income_statement (annual, 2025-06-30) — Basic EPS: -1.75
IBIO cash_flow (annual, 2025-06-30) — Beginning Cash Position: 14425000.00
IBIO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 5182000.00
IBIO balance_sheet (annual, 2025-06-30) — Buildings And Improvements: 695000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 695000.00
IBIO cash_flow (annual, 2025-06-30) — Capital Expenditure: -16000.00
IBIO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1000.00
IBIO balance_sheet (annual, 2025-06-30) — Capital Lease Obligations: 2742000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2742000.00
IBIO balance_sheet (annual, 2025-06-30) — Capital Stock: 19000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 19000.00
IBIO balance_sheet (annual, 2025-06-30) — Cash And Cash Equivalents: 8582000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 8582000.00
IBIO balance_sheet (annual, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 8582000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 8582000.00
IBIO cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Financing Activities: 8929000.00
IBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 8180000.00
IBIO cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Investing Activities: 742000.00
IBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 45000.00
IBIO cash_flow (annual, 2025-06-30) — Cash Flow From Continuing Operating Activities: -15304000.00
IBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -4615000.00
IBIO cash_flow (annual, 2025-06-30) — Change In Account Payable: 1831000.00
IBIO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 712000.00
IBIO cash_flow (annual, 2025-06-30) — Change In Accrued Expense: -758000.00
IBIO cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -54000.00
IBIO cash_flow (annual, 2025-06-30) — Change In Other Current Liabilities: -436000.00
IBIO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -113000.00
IBIO cash_flow (annual, 2025-06-30) — Change In Other Working Capital: 250000.00
IBIO cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -150000.00
IBIO cash_flow (annual, 2025-06-30) — Change In Payable: 1831000.00
IBIO cash_flow (quarterly, 2025-06-30) — Change In Payable: 712000.00
IBIO cash_flow (annual, 2025-06-30) — Change In Payables And Accrued Expense: 1073000.00
IBIO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 658000.00
IBIO cash_flow (annual, 2025-06-30) — Change In Prepaid Assets: -408000.00
IBIO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -387000.00
IBIO cash_flow (annual, 2025-06-30) — Change In Working Capital: 479000.00
IBIO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 8000.00
IBIO cash_flow (annual, 2025-06-30) — Changes In Cash: -5633000.00
IBIO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 3610000.00
IBIO balance_sheet (annual, 2025-06-30) — Common Stock: 19000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Common Stock: 19000.00
IBIO balance_sheet (annual, 2025-06-30) — Common Stock Equity: 14880000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 14880000.00
IBIO cash_flow (annual, 2025-06-30) — Common Stock Issuance: 3541000.00
IBIO cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 2410000.00
IBIO cash_flow (annual, 2025-06-30) — Common Stock Payments: 0.00
IBIO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
IBIO balance_sheet (annual, 2025-06-30) — Current Accrued Expenses: 469000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 469000.00
IBIO balance_sheet (annual, 2025-06-30) — Current Assets: 9721000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Current Assets: 9721000.00
IBIO balance_sheet (annual, 2025-06-30) — Current Capital Lease Obligation: 543000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 543000.00
IBIO balance_sheet (annual, 2025-06-30) — Current Debt: 766000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Current Debt: 766000.00
IBIO balance_sheet (annual, 2025-06-30) — Current Debt And Capital Lease Obligation: 1309000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1309000.00
IBIO balance_sheet (annual, 2025-06-30) — Current Deferred Liabilities: 1200000.00